Summit Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2017 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Summit Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2017 to Q3 2024.
  • Summit Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 23, 2024 was 737M shares, a 5.22% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 737M +36.6M +5.22% Oct 23, 2024 10-Q 2024-10-30
Q2 2024 725M +26.9M +3.85% Jul 30, 2024 10-Q 2024-08-06
Q1 2024 702M +4.29M +0.62% Apr 22, 2024 10-Q 2024-05-01
Q4 2023 702M Feb 9, 2024 10-K 2024-02-20
Q3 2023 701M +500M +248% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 698M +600M +611% Aug 2, 2023 10-Q 2023-08-09
Q1 2023 698M +600M +611% Mar 7, 2023 10-K 2023-03-09
Q3 2022 201M +104M +106% Nov 2, 2022 10-Q 2022-11-09
Q2 2022 98.1M +741K +0.76% Aug 4, 2022 10-Q 2022-08-11
Q1 2022 98.1M +15.2M +18.3% Mar 10, 2022 10-K/A 2022-12-21
Q3 2021 97.7M +15.5M +18.8% Nov 8, 2021 10-Q 2021-11-15
Q2 2021 97.4M Aug 5, 2021 10-Q 2021-08-12
Q1 2021 82.9M Mar 24, 2021 10-K 2021-03-31
Q3 2020 82.3M Nov 11, 2020 10-Q 2020-11-16
Q4 2019 336M +176M +109% Dec 31, 2019 20-F 2020-04-30
Q4 2018 160M +86.8M +118% Jan 31, 2019 20-F 2019-03-29
Q2 2018 0 Jun 5, 2018 6-K 2018-06-05
Q4 2017 73.6M Jan 31, 2018 20-F 2018-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.